Skyhawk Therapeutics is a clinical-stage biotechnology company focused on developing small molecules that modify RNA expression to treat various diseases, including Huntington's disease and other neurological and oncological conditions
Skyhawk Therapeutics is a clinical-stage biotechnology company focused on developing small molecules that modify RNA expression to treat various diseases, including Huntington's disease and other neurological and oncological conditions.
Skyhawk Therapeutics is a clinical-stage biotechnology company focused on developing small molecules that modify RNA expression to treat various diseases, including Huntington's disease and other neurological and oncological conditions
Skyhawk Therapeutics is a clinical-stage biotechnology company focused on developing small molecules that modify RNA expression to treat various diseases, including Huntington's disease and other neurological and oncological conditions.